Browse > Article
http://dx.doi.org/10.5012/jkcs.2018.62.5.377

Design, Synthesis and Biological Evaluation of Some Novel Chalcones-sulphonamide Hybrids  

Khanusiya, Mahammadali (Department of Chemistry, The HNSB Ltd Science College)
Gadhawala, Zakirhusen (Department of Chemistry, The HNSB Ltd Science College)
Publication Information
Abstract
A new class of Chalcone-Sulphonamide hybrids has been designed by condensing appropriate sulphonamide scaffold with substituted chalcones tethered by chloroacetyl chloride as a multi-target drug for therapeutic treatment. Chalcones were prepared by Claisen-Schmidt condensation of a substituted aldehyde with para aminoacetophenone. These Chalcone-Sulphonamide hybrids were screened by means of their antibacterial activity by NCCLS method. Among all these compounds, 5e and 5c displayed more potent growth inhibitory activity against Staphylococcus epidermidis and Pseudomonas aeruginosa bacteria respectively. Further, these hybrids were evaluated for their antifungal activity, among all hybrid 5a exhibited potent antifungal activity. The synthesized compounds were characterized by FT-IR, $^1HNMR$, $^{13}CNMR$ and HR-LCMS and spectral study supports the structures of synthesized Chalcone-Sulphonamide hybrids.
Keywords
Chalcones; Sulphonamide scaffold; Antibacterial; Antifungal;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Colliste, C. B.; Bail, L.; Trouillas, P.; Pouget, C.; Habrioux, G.; et al. Chalcone structural requirements for antioxidant, estrogenic and antiproliferative activities. Anticancer Res. 2001, 21, 3949.
2 Ngameni, B.; Kuete, V.; Ambassa, P.; Justine, K.; Marlyse, M. L; et al. Med. Chem. 2013, 3, 233.
3 Chandrabose, K.; Narayana, S. K.; Narayana, M.; Sakhtivel, R.; Uma, V.; Elungavan, M.; Devrajan, K.; Piyush, T.; et al. Recent Pat. Anticancer Drug Discov. 2015, 10, 1.
4 Chimenti, F.; Fioravanti, R.; Blasco, A.; Chimenti, P.; Secci, D.; Rossi, F.; et al. Chalcoes: A valid scaffold for mono amine oxidase inhibitors. J. Med. Chem. 2009, 52, 2818.   DOI
5 Kamal, A.; Prabhakar, S.; Ramaiah, M.; Venkat, R. P.; Ratna, R. C.; Malla, R. A.; Shankaraiha, N.; Lakshmi, N. R. T.; Pushpvalli, S.; Pal, B. M.; Eur. J. Med. Chem. 2011, 46, 3820.   DOI
6 Narender, T.; Venkateswarlu, K.; Vishnu, N. B.; Sarkar, S.; Tetrahedron Lett. 2011, 52, 5794.   DOI
7 Rajakumar, P.; Raja, S.; Tetrahedron Lett. 2008, 49, 6539.   DOI
8 Suvitha, S.; Siddig, I. A.; Mohammed, A. M.; Mohan, S.; Molecules 2012, 17, 6179.   DOI
9 Ratchanok, P.; Amporn, S.; Prasit, M.; Chanin, N.; Supaluk, P.; Somsak, R.; Virapong, P. Eur. J. Med. Chem. 2014, 85, 65.   DOI
10 Iqbal, H.; Prabhakar, V.; Sangita, A.; Chandrika, B.; Balasubramanium, R. Med. Chem. Res. 2014, 23, 4383.   DOI
11 Manik, D.; Kuntal, M. J. Toxicol. 2016, 1.
12 Fathalla, O. A.; Zaghary, W. A.; Radwan, H. H.; Awad, S. M.; Mohamed, S. M. Arch. Pharm. Res. 2002, 23, 258.
13 Van Leeuwen, R.; Katlama, C.; Kitchen, V.; et al. J. Infect. Dis. 1995, 171, 1166.   DOI
14 Owa, T.; Nagasu, T. Expert Opin. Ther. Pat. 2000, 10, 1725.   DOI
15 Sapuran, C. T.; Scozzafava, A.; Casini, A. Med. Res. Rev. 2003, 23, 146.   DOI
16 Thornber C. W. Chem. Soc. Rev. 1997, 8, 563.
17 Supuran, C. T.; Scozzafava, A. Immunol. Endocr. Metab. Agents Med. Chem. 2001, 1, 61.   DOI
18 Maren, T. H. Annu. Rev. Pharmacol. Toxicol. 1976, 16, 309.   DOI
19 Boyd, A. E. Diabetes 1988, 37, 847.   DOI
20 Selvam, P.; Chandramohan, M.; De Clerk, E.; Witvrous, M.; Pannerouque, C. Eur. J. Pharm. Sci. 2001, 14, 313.   DOI
21 Park, K. H.; Lee, J. W.; Ryu, Y. B.; Ryu, H. W.; Lee, S. A. Method for screening anticancer compounds inhibiting function of TM4SF5 and anticancer composition containing chalcone compounds. 2014, CA2671987C.
22 Chun, W. M.; Marzieh, Y.; Noorsaddah, A. R.; Kung, Y. B.; Pichika, M. R. Eur. J. Med. Chem. 2014, 77, 378.   DOI
23 Hamada, N. M. M.; Abdo, N. Y. M. Molecules 2015, 20, 10468.   DOI
24 Asha, V. C.; Ratnadeep, S. J.; Priyanka, G. M.; Charansingh, H. G. J. Korean Chem. Soc. 2011, 55, 776.   DOI